Question 1

Is Methyldopa-Sesquihydrate currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Methyldopa-Sesquihydrate has 4 active shortage notices across 2 countries (Germany, Netherlands). Status is refreshed daily from official regulatory sources.

Question 2

Why is Methyldopa-Sesquihydrate in shortage?

Accepted Answer

Regulators attribute the current Methyldopa-Sesquihydrate shortages to manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Methyldopa-Sesquihydrate shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 17 Apr 2026 to 31 Aug 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Methyldopa-Sesquihydrate shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
Germany	medium	3	2 Dec 2024	31 Aug 2026	BfArM
Netherlands	medium	1	13 Feb 2026	—	CBG-MEB

Methyldopa-Sesquihydrate shortage status

Where Methyldopa-Sesquihydrate is in shortage

Why Methyldopa-Sesquihydrate is in shortage

Recent shortage history

Frequently asked questions

Get alerted when Methyldopa-Sesquihydrate status changes